Items where Author is "Fletcher, H"
Up a level |
Number of items: 102.
Article
Abebe, M;
Doherty, TM;
Wassie, L;
Aseffa, A;
Bobosha, K;
Demissie, A;
Zewdie, M;
Engers, H;
Andersen, P;
Kim, L;
+7 more...
Huggett, J;
Rook, G;
Yamuah, LK;
Zumla, A;
VACSEL study group, . (, inc;
Fletcher, H;
);
(2010)
Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status.
European journal of immunology, 40 (1).
pp. 291-301.
ISSN 0014-2980
DOI: https://doi.org/10.1002/eji.200939856
Full text not available from this repository.
Abubakar, I;
Lipman, M;
McHugh, TD;
Fletcher, H;
(2016)
Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment.
BMC medicine, 14 (1).
p. 47.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-016-0599-1
Andrews, JR;
Nemes, E;
Tameris, M;
Landry, BS;
Mahomed, H;
McClain, JB;
Fletcher, HA;
Hanekom, WA;
Wood, R;
McShane, H;
+2 more...
Scriba, TJ;
Hatherill, M;
(2017)
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.
The lancet Respiratory medicine, 5 (4).
pp. 282-290.
ISSN 2213-2600
DOI: https://doi.org/10.1016/S2213-2600(17)30060-7
Berthoud, TK;
Dunachie, SJ;
Todryk, S;
Hill, AV;
Fletcher, HA;
(2009)
MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.
Journal of immunological methods, 340 (1).
pp. 33-41.
ISSN 0022-1759
DOI: https://doi.org/10.1016/j.jim.2008.09.021
Berthoud, TK;
Fletcher, H;
Porter, D;
Thompson, F;
Hill, AV;
Todryk, SM;
(2009)
Comparing human T cell and NK cell responses in viral-based malaria vaccine trials.
Vaccine, 28 (1).
pp. 21-7.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2009.09.132
Full text not available from this repository.
Berthoud, TK;
Hamill, M;
Lillie, PJ;
Hwenda, L;
Collins, KA;
Ewer, KJ;
Milicic, A;
Poyntz, HC;
Lambe, T;
Fletcher, HA;
+2 more...
Hill, AV;
Gilbert, SC;
(2011)
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
Clinical infectious diseases, 52 (1).
pp. 1-7.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/ciq015
Beveridge, NE;
Fletcher, HA;
Hughes, J;
Pathan, AA;
Scriba, TJ;
Minassian, A;
Sander, CR;
Whelan, KT;
Dockrell, HM;
Hill, AV;
+2 more...
Hanekom, WA;
McShane, H;
(2008)
A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
Tuberculosis (Edinburgh, Scotland), 88 (6).
pp. 631-40.
ISSN 1472-9792
DOI: https://doi.org/10.1016/j.tube.2008.06.005
Full text not available from this repository.
Brennan, MJ;
Tanner, R;
Morris, S;
Scriba, TJ;
Achkar, JM;
Zelmer, A;
Hokey, D;
Izzo, A;
Sharpe, S;
Williams, A;
+6 more...
Penn-Nicholson, A;
Erasmus, M;
Stylianou, E;
Hoft, DF;
McShane, H;
Fletcher, HA;
(2017)
The Cross-species Mycobacterial Growth Inhibition Assay (MGIA) Project 2010-2014.
Clinical and vaccine immunology.
ISSN 1556-6811
DOI: https://doi.org/10.1128/CVI.00142-17
Brookes, RH;
Hill, PC;
Owiafe, PK;
Ibanga, HB;
Jeffries, DJ;
Donkor, SA;
Fletcher, HA;
Hammond, AS;
Lienhardt, C;
Adegbola, RA;
+2 more...
McShane, H;
Hill, AV;
(2008)
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
PloS one, 3 (8).
e2921.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0002921
Chen, T;
Blanc, C;
Eder, AZ;
Prados-Rosales, R;
Souza, AC;
Kim, RS;
Glatman-Freedman, A;
Joe, M;
Bai, Y;
Lowary, TL;
+6 more...
Tanner, R;
Brennan, MJ;
Fletcher, HA;
McShane, H;
Casadevall, A;
Achkar, JM;
(2016)
Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.
The Journal of infectious diseases, 214 (2).
pp. 300-10.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jiw141
Full text not available from this repository.
Cobelens, F;
Nagelkerke, N;
Fletcher, H;
(2018)
The convergent epidemiology of tuberculosis and human cytomegalovirus infection.
F1000Research, 7.
p. 280.
ISSN 2046-1402
DOI: https://doi.org/10.12688/f1000research.14184.1
Demissie, A;
Abebe, M;
Aseffa, A;
Rook, G;
Fletcher, H;
Zumla, A;
Weldingh, K;
Brock, I;
Andersen, P;
Doherty, TM;
+1 more...
VACSEL Study Group;
(2004)
Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.
Journal of immunology (Baltimore, Md, 172 (11).
pp. 6938-43.
ISSN 0022-1767
DOI: https://doi.org/10.4049/jimmunol.172.11.6938
Full text not available from this repository.
Demissie, A;
Leyten, EM;
Abebe, M;
Wassie, L;
Aseffa, A;
Abate, G;
Fletcher, H;
Owiafe, P;
Hill, PC;
Brookes, R;
+8 more...
Rook, G;
Zumla, A;
Arend, SM;
Klein, M;
Ottenhoff, TH;
Andersen, P;
Doherty, TM;
VACSEL Study Group;
(2006)
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.
Clinical and vaccine immunology, 13 (2).
pp. 179-86.
ISSN 1556-6811
DOI: https://doi.org/10.1128/CVI.13.2.179-186.2006
Full text not available from this repository.
Dowd, JB;
Fletcher, HA;
Boccia, D;
(2018)
Social determinants and BCG efficacy: a call for a socio-biological approach to TB prevention.
F1000Research, 7.
p. 224.
ISSN 2046-1402
DOI: https://doi.org/10.12688/f1000research.14085.1
Dunachie, S;
Berthoud, T;
Hill, AV;
Fletcher, HA;
(2015)
Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2015.07.087
Dunachie, S;
Hill, AV;
Fletcher, HA;
(2015)
Profiling the host response to malaria vaccination and malaria challenge.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2015.07.107
Dunachie, SJ;
Berthoud, T;
Keating, SM;
Hill, AV;
Fletcher, HA;
(2010)
MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy.
PloS one, 5 (9).
e12557.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0012557
Dutruel, C;
Thole, J;
Geels, M;
Mollenkopf, HJ;
Ottenhoff, T;
Guzman, CA;
Fletcher, HA;
Leroy, O;
Kaufmann, SH;
(2014)
TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'How can big data help?'.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2014.06.014
Ferns, RB;
Fletcher, H;
Bradley, S;
Mackinnon, S;
Hunt, C;
Tedder, RS;
(2002)
The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment.
British journal of haematology, 119 (3).
pp. 720-5.
ISSN 0007-1048
DOI: https://doi.org/10.1046/j.1365-2141.2002.03862.x
Full text not available from this repository.
Fletcher, H;
(2015)
Profiling the host immune response to tuberculosis vaccines.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2015.07.090
Full text not available from this repository.
Fletcher, H;
McShane, H;
(2006)
Tuberculosis vaccines: current status and future prospects.
Expert opinion on emerging drugs, 11 (2).
pp. 207-15.
ISSN 1472-8214
DOI: https://doi.org/10.1517/14728214.11.2.207
Full text not available from this repository.
Fletcher, HA;
(2007)
Correlates of immune protection from tuberculosis.
Current molecular medicine, 7 (3).
pp. 319-25.
ISSN 1566-5240
DOI: https://doi.org/10.2174/156652407780598520
Full text not available from this repository.
Fletcher, HA;
(2001)
Molecular epidemiology of tuberculosis: recent developments and applications.
Current opinion in pulmonary medicine, 7 (3).
pp. 154-9.
ISSN 1070-5287
http://researchonline.lshtm.ac.uk/id/eprint/1217160
Full text not available from this repository.
Fletcher, HA;
(2016)
Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine.
mBio, 7 (4).
ISSN 2150-7511
DOI: https://doi.org/10.1128/mBio.01370-16
Fletcher, HA;
(2018)
Systems approaches to correlates of protection and progression to TB disease.
Seminars in immunology.
ISSN 1044-5323
DOI: https://doi.org/10.1016/j.smim.2018.10.001
Full text not available from this repository.
Fletcher, HA;
Chatterjee, M;
Cooper, A;
Hussell, T;
Kaye, PM;
Prior, J;
Reljic, R;
Vermaak, S;
Vordermeier, M;
Williams, A;
+1 more...
McShane, H;
(2018)
VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy.
F1000Research, 7.
p. 485.
ISSN 2046-1402
DOI: https://doi.org/10.12688/f1000research.14386.1
Fletcher, HA;
Dockrell, HM;
(2016)
Human biomarkers: can they help us to develop a new tuberculosis vaccine?
Future microbiology, 11.
pp. 781-7.
ISSN 1746-0913
DOI: https://doi.org/10.2217/fmb.16.15
Fletcher, HA;
Donoghue, HD;
Holton, J;
Pap, I;
Spigelman, M;
(2003)
Widespread occurrence of Mycobacterium tuberculosis DNA from 18th-19th century Hungarians.
American journal of physical anthropology, 120 (2).
pp. 144-52.
ISSN 0002-9483
DOI: https://doi.org/10.1002/ajpa.10114
Full text not available from this repository.
Fletcher, HA;
Donoghue, HD;
Taylor, GM;
van der Zanden, AG;
Spigelman, M;
(2003)
Molecular analysis of Mycobacterium tuberculosis DNA from a family of 18th century Hungarians.
Microbiology (Reading, England), 149 (Pt 1).
pp. 143-51.
ISSN 1350-0872
DOI: https://doi.org/10.1099/mic.0.25961-0
Full text not available from this repository.
Fletcher, HA;
Filali-Mouhim, A;
Nemes, E;
Hawkridge, A;
Keyser, A;
Njikan, S;
Hatherill, M;
Scriba, TJ;
Abel, B;
Kagina, BM;
+32 more...
Veldsman, A;
Agudelo, NM;
Kaplan, G;
Hussey, GD;
Sekaly, RP;
Hanekom, WA;
BCG study team;
, COLLABORATORS;
Minnies, D;
Tanner, R;
Chung, CK;
Cameron, MJ;
Goulet, JP;
Gaujoux, R;
Hughes, J;
Gelderbloem, S;
Iloni, K;
Buchanan, M;
van der Merwe, L;
Burger, A;
Denation, L;
Mlanjeni, S;
Abrahams, S;
Shepherd, R;
Geldenhuys, M;
Seoighe, C;
Soares, A;
Gamieldien, H;
Sidibana, M;
Mahomed, H;
McShane, H;
Hill, AV;
(2016)
Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.
BMC medicine, 14 (1).
p. 76.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-016-0617-3
Fletcher, HA;
Hawkridge, T;
McShane, H;
(2009)
A New Vaccine for Tuberculosis: The Challenges of Development and Deployment.
Journal of bioethical inquiry, 6 (2).
pp. 219-228.
ISSN 1176-7529
DOI: https://doi.org/10.1007/s11673-009-9153-6
Fletcher, HA;
Keyser, A;
Bowmaker, M;
Sayles, PC;
Kaplan, G;
Hussey, G;
Hill, AV;
Hanekom, WA;
(2009)
Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth.
BMC medical genomics, 2.
p. 10.
ISSN 1755-8794
DOI: https://doi.org/10.1186/1755-8794-2-10
Fletcher, HA;
Owiafe, P;
Jeffries, D;
Hill, P;
Rook, GA;
Zumla, A;
Doherty, TM;
Brookes, RH;
Vacsel Study Group;
(2004)
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.
Immunology, 112 (4).
pp. 669-73.
ISSN 0019-2805
DOI: https://doi.org/10.1111/j.1365-2567.2004.01922.x
Full text not available from this repository.
Fletcher, HA;
Pathan, AA;
Berthoud, TK;
Dunachie, SJ;
Whelan, KT;
Alder, NC;
Sander, CR;
Hill, AV;
McShane, H;
(2008)
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
Vaccine, 26 (41).
pp. 5269-75.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2008.07.040
Fletcher, HA;
Schrager, L;
(2016)
TB vaccine development and the End TB Strategy: importance and current status.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 110 (4).
pp. 212-8.
ISSN 0035-9203
DOI: https://doi.org/10.1093/trstmh/trw016
Fletcher, HA;
Snowden, MA;
Landry, B;
Rida, W;
Satti, I;
Harris, SA;
Matsumiya, M;
Tanner, R;
O'Shea, MK;
Dheenadhayalan, V;
+20 more...
Bogardus, L;
Stockdale, L;
Marsay, L;
Chomka, A;
Harrington-Kandt, R;
Manjaly-Thomas, ZR;
Naranbhai, V;
Stylianou, E;
Darboe, F;
Penn-Nicholson, A;
Nemes, E;
Hatheril, M;
Hussey, G;
Mahomed, H;
Tameris, M;
McClain, JB;
Evans, TG;
Hanekom, WA;
Scriba, TJ;
McShane, H;
(2016)
T-cell activation is an immune correlate of risk in BCG vaccinated infants.
Nature communications, 7.
p. 11290.
ISSN 2041-1723
DOI: https://doi.org/10.1038/ncomms11290
Fletcher, HA;
Tanner, R;
Wallis, RS;
Meyer, J;
Manjaly, ZR;
Harris, S;
Satti, I;
Silver, RF;
Hoft, D;
Kampmann, B;
+6 more...
Walker, KB;
Dockrell, HM;
Fruth, U;
Barker, L;
Brennan, MJ;
McShane, H;
(2013)
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
Clinical and vaccine immunology, 20 (11).
pp. 1683-9.
ISSN 1556-6811
DOI: https://doi.org/10.1128/CVI.00427-13
Full text not available from this repository.
Griffiths, KL;
Pathan, AA;
Minassian, AM;
Sander, CR;
Beveridge, NE;
Hill, AV;
Fletcher, HA;
McShane, H;
(2011)
Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
PloS one, 6 (8).
e23463.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0023463
Griffiths, KL;
Stylianou, E;
Poyntz, HC;
Betts, GJ;
Fletcher, HA;
McShane, H;
(2013)
Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.
PloS one, 8 (10).
e78312.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0078312
Gupta-Wright, A;
Tomlinson, GS;
Rangaka, MX;
Fletcher, HA;
(2018)
World TB Day 2018: The Challenge of Drug Resistant Tuberculosis.
F1000Research, 7.
p. 217.
ISSN 2046-1402
DOI: https://doi.org/10.12688/f1000research.14088.1
Hanekom, WA;
Dockrell, HM;
Ottenhoff, TH;
Doherty, TM;
Fletcher, H;
McShane, H;
Weichold, FF;
Hoft, DF;
Parida, SK;
Fruth, UJ;
(2008)
Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations.
PLoS medicine, 5 (7).
e145.
ISSN 1549-1277
DOI: https://doi.org/10.1371/journal.pmed.0050145
Harris, SA;
Meyer, J;
Satti, I;
Marsay, L;
Poulton, ID;
Tanner, R;
Minassian, AM;
Fletcher, HA;
McShane, H;
(2013)
Evaluation of a human BCG challenge model to assess anti-mycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination.
The Journal of infectious diseases.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jit647
Harris, SA;
Satti, I;
Matsumiya, M;
Stockdale, L;
Chomka, A;
Tanner, R;
O'Shea, MK;
Manjaly Thomas, ZR;
Tameris, M;
Mahomed, H;
+4 more...
Scriba, TJ;
Hanekom, WA;
Fletcher, HA;
McShane, H;
(2014)
Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A.
Clinical and vaccine immunology, 21 (7).
pp. 1005-11.
ISSN 1556-6811
DOI: https://doi.org/10.1128/CVI.00128-14
Hawkridge, T;
Scriba, TJ;
Gelderbloem, S;
Smit, E;
Tameris, M;
Moyo, S;
Lang, T;
Veldsman, A;
Hatherill, M;
Merwe, Lv;
+6 more...
Fletcher, HA;
Mahomed, H;
Hill, AV;
Hanekom, WA;
Hussey, GD;
McShane, H;
(2008)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
The Journal of infectious diseases, 198 (4).
pp. 544-52.
ISSN 0022-1899
DOI: https://doi.org/10.1086/590185
Full text not available from this repository.
Ibanga, HB;
Brookes, RH;
Hill, PC;
Owiafe, PK;
Fletcher, HA;
Lienhardt, C;
Hill, AV;
Adegbola, RA;
McShane, H;
(2006)
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.
The Lancet infectious diseases, 6 (8).
pp. 522-8.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(06)70552-7
Full text not available from this repository.
Jenjaroen, K;
Chumseng, S;
Sumonwiriya, M;
Ariyaprasert, P;
Chantratita, N;
Sunyakumthorn, P;
Hongsuwan, M;
Wuthiekanun, V;
Fletcher, HA;
Teparrukkul, P;
+3 more...
Limmathurotsakul, D;
Day, NP;
Dunachie, SJ;
(2015)
T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients.
PLoS neglected tropical diseases, 9 (10).
e0004152.
ISSN 1935-2727
DOI: https://doi.org/10.1371/journal.pntd.0004152
Joosten, SA;
Fletcher, HA;
Ottenhoff, TH;
(2013)
A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis.
PloS one, 8 (9).
e73230.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0073230
Karam, F;
Mbow, F;
Fletcher, H;
Senghor, CS;
Coulibaly, KD;
Lefevre, AM;
Ngom Gueye, NF;
Dieye, T;
Sow, PS;
Mboup, S;
+1 more...
Lienhardt, C;
(2008)
Sensitivity of IFN-gamma Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression.
PloS one, 3 (1).
e1441.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0001441
Kasolo, F;
Lishimpi, K;
Chintu, C;
Mwaba, P;
Mudenda, V;
Maswahu, D;
Terunuma, H;
Fletcher, H;
Nunn, A;
Lucas, S;
+1 more...
Zumla, A;
(2002)
Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory tract illnesses.
The Journal of pediatrics, 140 (3).
pp. 367-9.
ISSN 0022-3476
DOI: https://doi.org/10.1067/mpd.2002.122468
Full text not available from this repository.
Kasprowicz, VO;
Mitchell, JE;
Chetty, S;
Govender, P;
Huang, KH;
Fletcher, HA;
Webster, DP;
Brown, S;
Kasmar, A;
Millington, K;
+8 more...
Day, CL;
Mkhwanazi, N;
McClurg, C;
Chonco, F;
Lalvani, A;
Walker, BD;
Ndung'u, T;
Klenerman, P;
(2011)
A molecular assay for sensitive detection of pathogen-specific T-cells.
PloS one, 6 (8).
e20606.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0020606
Kaufmann, SH;
Fletcher, HA;
Guzman, CA;
Ottenhoff, TH;
(2015)
Introduction and section summaries.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2015.04.078
Full text not available from this repository.
Kewcharoenwong, C;
Prabowo, SA;
Bancroft, GJ;
Fletcher, HA;
Lertmemongkolchai, G;
(2018)
Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization.
Frontiers in immunology, 9.
p. 2109.
ISSN 1664-3224
DOI: https://doi.org/10.3389/fimmu.2018.02109
Khan, MS;
Fletcher, H;
London School of Hygiene and Tropical Medicine TB Centre Steerin;
Coker, R;
(2016)
Investments in tuberculosis research - what are the gaps?
BMC medicine, 14 (1).
p. 123.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-016-0644-0
Lienhardt, C;
Fielding, K;
Hane, AA;
Niang, A;
Ndao, CT;
Karam, F;
Fletcher, H;
Mbow, F;
Gomis, JF;
Diadhiou, R;
+4 more...
Diadhiou, R;
Toupane, M;
Dieye, T;
Mboup, S;
(2010)
Evaluation of the Prognostic Value of IFN-gamma Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal.
PloS one, 5 (5).
e10508.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0010508
Marsay, L;
Matsumiya, M;
Tanner, R;
Poyntz, H;
Griffiths, KL;
Stylianou, E;
Marsh, PD;
Williams, A;
Sharpe, S;
Fletcher, H;
+1 more...
McShane, H;
(2013)
Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
Tuberculosis (Edinburgh, Scotland), 93 (5).
pp. 551-7.
ISSN 1472-9792
DOI: https://doi.org/10.1016/j.tube.2013.04.007
Matsumiya, M;
Harris, SA;
Satti, I;
Stockdale, L;
Tanner, R;
O'Shea, MK;
Tameris, M;
Mahomed, H;
Hatherill, M;
Scriba, TJ;
+3 more...
Hanekom, WA;
McShane, H;
Fletcher, HA;
(2014)
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
BMC infectious diseases, 14 (1).
p. 314.
ISSN 1471-2334
DOI: https://doi.org/10.1186/1471-2334-14-314
Matsumiya, M;
Satti, I;
Chomka, A;
Harris, SA;
Stockdale, L;
Meyer, J;
Fletcher, HA;
McShane, H;
(2014)
Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model.
The Journal of infectious diseases.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jiu615
Matsumiya, M;
Stylianou, E;
Griffiths, K;
Lang, Z;
Meyer, J;
Harris, SA;
Rowland, R;
Minassian, AM;
Pathan, AA;
Fletcher, H;
+1 more...
McShane, H;
(2013)
Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A.
PloS one, 8 (7).
e67922.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0067922
McNeill, Eileen;
Stylianou, Elena;
Crabtree, Mark J;
Harrington-Kandt, Rachel;
Kolb, Anna-Lena;
Diotallevi, Marina;
Hale, Ashley B;
Bettencourt, Paulo;
Tanner, Rachel;
O'Shea, Matthew K;
+7 more...
Matsumiya, Magali;
Lockstone, Helen;
Mueller, Julius;
Fletcher, Helen A;
Greaves, David R;
McShane, Helen;
Channon, Keith M;
(2018)
Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin.
NATURE COMMUNICATIONS, 9 (1).
ISSN 2041-1723
DOI: https://doi.org/10.1038/s41467-018-07714-9
McShane, H;
Pathan, AA;
Sander, CR;
Goonetilleke, NP;
Fletcher, HA;
Hill, AV;
(2005)
Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
Tuberculosis (Edinburgh, Scotland), 85 (1-2).
pp. 47-52.
ISSN 1472-9792
DOI: https://doi.org/10.1016/j.tube.2004.09.015
Full text not available from this repository.
McShane, H;
Pathan, AA;
Sander, CR;
Keating, SM;
Gilbert, SC;
Huygen, K;
Fletcher, HA;
Hill, AV;
(2004)
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
Nature medicine, 10 (11).
pp. 1240-4.
ISSN 1078-8956
DOI: https://doi.org/10.1038/nm1128
Full text not available from this repository.
Meyer, J;
Harris, SA;
Satti, I;
Poulton, ID;
Poyntz, HC;
Tanner, R;
Rowland, R;
Griffiths, KL;
Fletcher, HA;
McShane, H;
(2013)
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
Vaccine, 31 (7).
pp. 1026-33.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2012.12.042
Full text not available from this repository.
Minassian, AM;
Rowland, R;
Beveridge, NE;
Poulton, ID;
Satti, I;
Harris, S;
Poyntz, H;
Hamill, M;
Griffiths, K;
Sander, CR;
+16 more...
Ambrozak, DR;
Price, DA;
Hill, BJ;
Casazza, JP;
Douek, DC;
Koup, RA;
Roederer, M;
Winston, A;
Ross, J;
Sherrard, J;
Rooney, G;
Williams, N;
Lawrie, AM;
Fletcher, HA;
Pathan, AA;
McShane, H;
(2011)
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults.
BMJ open, 1 (2).
e000223.
ISSN 2044-6055
DOI: https://doi.org/10.1136/bmjopen-2011-000223
Mwacharo, J;
Dunachie, SJ;
Kai, O;
Hill, AV;
Bejon, P;
Fletcher, HA;
(2009)
Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.
PloS one, 4 (12).
e8434.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0008434
Naranbhai, V;
Fletcher, HA;
Tanner, R;
O'Shea, MK;
McShane, H;
Fairfax, BP;
Knight, JC;
Hill, AV;
(2015)
Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.
EBioMedicine, 2 (11).
pp. 1619-1626.
ISSN 2352-3964
DOI: https://doi.org/10.1016/j.ebiom.2015.09.027
Naranbhai, V;
Hill, AV;
Abdool Karim, SS;
Naidoo, K;
Abdool Karim, Q;
Warimwe, GM;
McShane, H;
Fletcher, H;
(2013)
Blood monocyte-lymphocyte ratios identify adults at risk of incident tuberculosis amongst patients initiating antiretroviral therapy.
The Journal of infectious diseases.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jit494
Naranbhai, V;
Kim, S;
Fletcher, H;
Cotton, MF;
Violari, A;
Mitchell, C;
Nachman, S;
McSherry, G;
McShane, H;
Hill, A;
+1 more...
Madhi, SA;
(2014)
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life.
BMC medicine, 12 (1).
p. 120.
ISSN 1741-7015
DOI: https://doi.org/10.1186/PREACCEPT-2435299671185919
Naranbhai, V;
Moodley, D;
Chipato, T;
Stranix-Chibanda, L;
Nakabaiito, C;
Kamateeka, M;
Musoke, P;
Manji, K;
George, K;
Emel, LM;
+8 more...
Richardson, P;
Andrew, P;
Fowler, M;
Fletcher, H;
Mcshane, H;
Coovadia, HM;
Hill, AV;
for the HPTN 046 protocol team;
(2014)
The association between the ratio of monocytes: lymphocytes and risk of tuberculosis(TB) amongst HIV infected postpartum women.
Journal of acquired immune deficiency syndromes (1999).
ISSN 1525-4135
DOI: https://doi.org/10.1097/QAI.0000000000000353
Full text not available from this repository.
Pathan, AA;
Minassian, AM;
Sander, CR;
Rowland, R;
Porter, DW;
Poulton, ID;
Hill, AV;
Fletcher, HA;
McShane, H;
(2012)
Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Vaccine, 30 (38).
pp. 5616-24.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2012.06.084
Pathan, AA;
Sander, CR;
Fletcher, HA;
Poulton, I;
Alder, NC;
Beveridge, NE;
Whelan, KT;
Hill, AV;
McShane, H;
(2007)
Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
PloS one, 2 (10).
e1052.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0001052
Phillips, PP;
Fletcher, HA;
Abubakar, I;
Lipman, MC;
McHugh, TD;
(2016)
World TB Day 2016: an interview with leading experts in tuberculosis research.
BMC medicine, 14 (1).
p. 55.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-016-0591-9
Prabowo, Satria A;
Zelmer, Andrea;
Stockdale, Lisa;
Ojha, Utkarsh;
Smith, Steven G;
Seifert, Karin;
Fletcher, Helen A;
(2019)
Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells.
SCIENTIFIC REPORTS, 9 (1).
ISSN 2045-2322
DOI: https://doi.org/10.1038/s41598-019-41008-4
Rakotosamimanana, N;
Raharimanga, V;
Andriamandimby, SF;
Soares, JL;
Doherty, TM;
Ratsitorahina, M;
Ramarokoto, H;
Zumla, A;
Huggett, J;
Rook, G;
+5 more...
Richard, V;
Gicquel, B;
Rasolofo-Razanamparany, V;
VACSEL/VACSIS Study Group, . (inc. Fletcher, H;
);
(2010)
Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar.
Clinical and vaccine immunology, 17 (7).
pp. 1094-103.
ISSN 1556-6811
DOI: https://doi.org/10.1128/CVI.00049-10
Full text not available from this repository.
Rhodes, SJ;
Guedj, J;
Fletcher, HA;
Lindenstrøm, T;
Scriba, TJ;
Evans, TG;
Knight, GM;
White, RG;
(2018)
Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making.
NPJ Vaccines, 3.
p. 36.
ISSN 2059-0105
DOI: https://doi.org/10.1038/s41541-018-0075-3
Rhodes, SJ;
Knight, GM;
Fielding, K;
Scriba, TJ;
Pathan, AA;
McShane, H;
Fletcher, H;
White, RG;
(2015)
Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.
Tuberculosis (Edinburgh, Scotland), 96.
pp. 37-43.
ISSN 1472-9792
DOI: https://doi.org/10.1016/j.tube.2015.10.002
Rhodes, SJ;
Sarfas, C;
Knight, GM;
White, A;
Pathan, AA;
McShane, H;
Evans, TG;
Fletcher, H;
Sharpe, S;
White, RG;
(2017)
Predicting IFN-γ responses after BCG vaccination in humans from macaques: A proof-of-concept study of Immunostimulation/Immunodynamic modelling methods.
Clinical and vaccine immunology.
ISSN 1556-6811
DOI: https://doi.org/10.1128/CVI.00525-16
Rhodes, SJ;
Zelmer, A;
Knight, GM;
Prabowo, SA;
Stockdale, L;
Evans, TG;
Lindenstrøm, T;
White, RG;
Fletcher, H;
(2016)
The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2016.10.060
Schito, M;
Migliori, GB;
Fletcher, HA;
McNerney, R;
Centis, R;
D'Ambrosio, L;
Bates, M;
Kibiki, G;
Kapata, N;
Corrah, T;
+6 more...
Bomanji, J;
Vilaplana, C;
Johnson, D;
Mwaba, P;
Maeurer, M;
Zumla, A;
(2015)
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
Clinical infectious diseases, 61 (suppl).
S102-S118.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/civ609
Full text not available from this repository.
Scriba, TJ;
Coussens, AK;
Fletcher, HA;
(2016)
Human Immunology of Tuberculosis.
Microbiology spectrum, 4 (5).
ISSN 2165-0497
DOI: https://doi.org/10.1128/microbiolspec.TBTB2-0016-2016
Full text not available from this repository.
Scriba, TJ;
Coussens, AK;
Fletcher, HA;
(2017)
Human Immunology of Tuberculosis.
Microbiology Spectrum, 5 (1).
p. 24.
DOI: https://doi.org/10.1128/microbiolspec.TBTB2-0016-2016
Full text not available from this repository.
Scriba, Thomas J;
Coussens, Anna K;
Fletcher, Helen A;
(2017)
Human Immunology of Tuberculosis.
Microbiology Spectrum, 5 (1).
ISSN 2165-0497
DOI: https://doi.org/10.1128/microbiolspec.tbtb2-0016-2016
Sibley, Laura;
Gooch, Karen;
Wareham, Alice;
Gray, Susan;
Chancellor, Andrew;
Dowall, Stuart;
Bate, Simon;
Marriott, Anthony;
Dennis, Mike;
White, Andrew D;
+3 more...
Marsh, Philip D;
Fletcher, Helen;
Sharpe, Sally;
(2019)
Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques.
Scientific reports, 9 (1).
p. 3340.
ISSN 2045-2322
DOI: https://doi.org/10.1038/s41598-019-39819-6
Smith, SG;
Smits, K;
Joosten, SA;
van Meijgaarden, KE;
Satti, I;
Fletcher, HA;
Caccamo, N;
Dieli, F;
Mascart, F;
McShane, H;
+3 more...
Dockrell, HM;
Ottenhoff, TH;
TBVI TB Biomarker Working Group;
(2015)
Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines.
PloS one, 10 (9).
e0138042.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0138042
Stockdale, L;
Nash, S;
Nalwoga, A;
Painter, H;
Asiki, G;
Fletcher, H;
Newton, R;
(2018)
Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.
PloS one, 13 (2).
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0192086
Tanner, R;
Kakalacheva, K;
Miller, E;
Pathan, AA;
Chalk, R;
Sander, CR;
Scriba, T;
Tameris, M;
Hawkridge, T;
Mahomed, H;
+5 more...
Hussey, G;
Hanekom, W;
Checkley, A;
McShane, H;
Fletcher, HA;
(2014)
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.
BMC infectious diseases, 14.
p. 660.
ISSN 1471-2334
DOI: https://doi.org/10.1186/s12879-014-0660-7
Tanner, R;
O'Shea, MK;
Fletcher, HA;
McShane, H;
(2016)
In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy.
Vaccine, 34 (39).
pp. 4656-4665.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2016.07.058
Tanner, R;
O'Shea, MK;
White, AD;
Müller, J;
Harrington-Kandt, R;
Matsumiya, M;
Dennis, MJ;
Parizotto, EA;
Harris, S;
Stylianou, E;
+6 more...
Naranbhai, V;
Bettencourt, P;
Drakesmith, H;
Sharpe, S;
Fletcher, HA;
McShane, H;
(2017)
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.
Scientific reports, 7.
p. 43478.
ISSN 2045-2322
DOI: https://doi.org/10.1038/srep43478
Vainieri, ML;
Blagborough, AM;
MacLean, AL;
Haltalli, ML;
Ruivo, N;
Fletcher, HA;
Stumpf, MP;
Sinden, RE;
Celso, CL;
(2016)
Systematic tracking of altered haematopoiesis during sporozoite-mediated malaria development reveals multiple response points.
Open biology, 6 (6).
ISSN 2046-2441
DOI: https://doi.org/10.1098/rsob.160038
Voss, G;
Casimiro, D;
Neyrolles, O;
Williams, A;
Kaufmann, SHE;
McShane, H;
Hatherill, M;
Fletcher, HA;
(2018)
Progress and challenges in TB vaccine development.
F1000Research, 7.
p. 199.
ISSN 2046-1402
DOI: https://doi.org/10.12688/f1000research.13588.1
Walther, M;
Tongren, JE;
Andrews, L;
Korbel, D;
King, E;
Fletcher, H;
Andersen, RF;
Bejon, P;
Thompson, F;
Dunachie, SJ;
+6 more...
Edele, F;
de Souza, JB;
Sinden, RE;
Gilbert, SC;
Riley, EM;
Hill, AV;
(2005)
Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection.
Immunity, 23 (3).
pp. 287-96.
ISSN 1074-7613
DOI: https://doi.org/10.1016/j.immuni.2005.08.006
Full text not available from this repository.
Warimwe, GM;
Fletcher, HA;
Olotu, A;
Agnandji, ST;
Hill, AV;
Marsh, K;
Bejon, P;
(2013)
Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
BMC medicine, 11 (1).
p. 184.
ISSN 1741-7015
DOI: https://doi.org/10.1186/1741-7015-11-184
Warimwe, GM;
Murungi, LM;
Kamuyu, G;
Nyangweso, GM;
Wambua, J;
Naranbhai, V;
Fletcher, HA;
Hill, AV;
Bejon, P;
Osier, FH;
+1 more...
Marsh, K;
(2013)
The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.
PloS one, 8 (2).
e57320.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0057320
Wassie, L;
Demissie, A;
Aseffa, A;
Abebe, M;
Yamuah, L;
Tilahun, H;
Petros, B;
Rook, G;
Zumla, A;
Andersen, P;
+3 more...
Doherty, TM;
VACSEL Study Group, . (inc. Fletcher, H;
);
(2008)
Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time.
PloS one, 3 (1).
e1522.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0001522
Whelan, KT;
Pathan, AA;
Sander, CR;
Fletcher, HA;
Poulton, I;
Alder, NC;
Hill, AV;
McShane, H;
(2009)
Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
PloS one, 4 (6).
e5934.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0005934
Zelmer, A;
Stockdale, L;
Prabowo, SA;
Cia, F;
Spink, N;
Gibb, M;
Eddaoudi, A;
Fletcher, HA;
(2018)
High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis.
F1000Research, 7.
p. 296.
ISSN 2046-1402
DOI: https://doi.org/10.12688/f1000research.14239.1
Zelmer, A;
Tanner, R;
Stylianou, E;
Damelang, T;
Morris, S;
Izzo, A;
Williams, A;
Sharpe, S;
Pepponi, I;
Walker, B;
+4 more...
Hokey, DA;
McShane, H;
Brennan, M;
Fletcher, H;
(2016)
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
BMC infectious diseases, 16.
p. 412.
ISSN 1471-2334
DOI: https://doi.org/10.1186/s12879-016-1751-4
de Cassan, SC;
Pathan, AA;
Sander, CR;
Minassian, A;
Rowland, R;
Hill, AV;
McShane, H;
Fletcher, HA;
(2010)
Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
Clinical and vaccine immunology, 17 (7).
pp. 1066-73.
ISSN 1556-6811
DOI: https://doi.org/10.1128/CVI.00047-10
Full text not available from this repository.
Conference or Workshop Item
Griffiths, K;
Stylianou, E;
Poyntz, H;
Betts, G;
Fletcher, H;
McShane, H;
Beveridge, N;
Minassian, A;
Rowland, R;
Poulton, I;
+22 more...
Satti, I;
Harris, S;
Poyntz, H;
Hamill, M;
Griffiths, K;
Sander, C;
Ambrozak, D;
Price, D;
Hill, B;
Casazza, J;
Douek, D;
Koup, R;
Roederer, M;
Winston, A;
Ross, J;
Sherrad, J;
Rooney, G;
Williams, N;
Lawrie, A;
Fletcher, H;
Pathan, A;
McShane, H;
(2011)
Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
CD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults SO IMMUNOLOGY CT Annual Congress of the British-Society-for-Immunology CY DEC 05-08, 2011 CL Liverpool, ENGLAND SP British Soc Immunol.
[Conference or Workshop Item]
http://researchonline.lshtm.ac.uk/id/eprint/2729027
Full text not available from this repository.
Moore, CE;
Hennig, BJ;
Perrett, KP;
Hoe, JC;
Lee, SJ;
Fletcher, H;
Brocklebank, D;
O'Connor, D;
Snape, MD;
Hall, AJ;
+3 more...
Segal, S;
Hill, AVS;
Pollard, AJ;
(2011)
Single Nucleotide Polymorphisms in the Toll-Like Receptor 3 and CD44 Genes Are Associated with Persistence of Vaccine-Induced Immunity to the Serogroup C Meningococcal Conjugate Vaccine.
[Conference or Workshop Item]
https://doi.org/10.1128/CVI.05379-11
Full text not available from this repository.
Sander, CR;
Tchilian, E;
Dahm-Vicker, M;
Fletcher, H;
McShane, H;
Hill, AVS;
(2006)
New tuberculosis vaccines can diminish as well as enhance BCG induced protection: Results from a murine model SO THORAX CT Winter Meeting of the British-Thoracic-Society/British-Lung-Foundation (BTS/BLF).
[Conference or Workshop Item]
http://researchonline.lshtm.ac.uk/id/eprint/2729022
Full text not available from this repository.
Thesis
Rhodes, SJ;
(2018)
The development of a mathematical modelling framework to translate TB vaccine responses between species and predict the most immunogenic dose in humans using animal data.
PhD (research paper style) thesis, London School of Hygiene & Tropical Medicine.
DOI: https://doi.org/10.17037/PUBS.04647153